Prevalence of tuberculosis infection in the United States population: The national health and nutrition examination survey, 1999-2000

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 3, 2008, Pages 348-355

  Bennett, Diane E ^a   Courval, Jeanne M ^b   Onorato, Ida ^a   Agerton, Tracy ^a   Gibson, Judy D ^a   Lambert, Lauren ^a   McQuillan, Geraldine M ^c   Lewis, Brenda ^c   Navin, Thomas R ^a,d   Castro, Kenneth G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RTI INTERNATIONAL   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d Mailstop E 10 ^*  (United States)

Author keywords

Epidemiology; Tuberculin test; Tuberculosis infection; United States

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NUTRITION SURVEYS; POVERTY; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 38849206758     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200701-057OC     Document Type: Article

References (39)

1. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-539.
2. U.S. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2005 [Internet]. Atlanta (GA): U.S. Department of Health and Human Services; 2006 Sep [accessed 2007 Jan 7]. Available from: http://www.cdc.gov/tb/surv/surv2005/default.htm
3. U.S. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38:1-25.
4. Geiter L, editor. Ending neglect: the elimination of tuberculosis in the United States. 1st ed. Washington (DC): National Academy Press; 2000.
5. Onorato I. TB outbreaks in the United States. Int J Tuberc Lung Dis 2000;4:S121-S126.
6. Styblo K. The elimination of tuberculosis in the Netherlands. Bull Int Union Tuberc Lung Dis 1990;65:49-55.
7. Bennett DE, Onorato IM, Courval J, Agerton T, Daugherty-Gibson J, Lambert L, McQuillan G, Lewis B, Castro K. Prevalence of TB infection in the U.S. population [abstract 385]. 33rd International Union of Tuberculosis and Lung Disease Conference on Lung Health, Paris, France; November 2002.
8. Bennett DE, Onorato IM, Courval J, Agerton T, Daugherty-Gibson J, Lambert L, McQuillan G, Lewis B, Castro K. Prevalence of TB infection in the U.S. population [abstract 67921]. 131st American Public Health Association Annual Meeting, San Francisco, California; November 2003
9. U.S. Centers for Disease Control and Prevention. NHANES analytic guidelines. June 2004 version [accessed 2007 Aug 1]. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_general_guidelines_june_04.pdf
10. Seibert FB, Munday B. Chemical composition of active principle of tuberculin; precipitated purified protein suitable for preparation of standard tuberculin. Am Rev Tuberc 1934;30:482-484.
11. Rust P, Edwards LB, Hopwood L, Palmer CE. Identification of mycobacterial infections. Bull World Health Organ 1965;33:405-412.
12. Edwards LB, Acquaviva FA, Livesay VT. Identification of tuberculous infected: dual tests and density of reaction. Am Rev Respir Dis 1973; 108:1334-1339.
13. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 2000;49:1-51.
14. U.S. Centers for Disease Control and Prevention. NHANES 1999-2000 data release sample weights to use with particular data files [accessed 2007 Jan 5]. Available from: http://www.cdc.gov/nchs/nhanes.htm.
15. Kalton G, Flores-Cervantes I. Weighting methods. J Off Stat 2003;19:81-97.
16. U.S. Centers for Disease Control and Prevention. Trends in tuberculosis morbidity - United States, 1992-2002. MMWR Morb Mortal Wkly Rep 2003;51:217-224.
17. Horsburgh CR Jr. Priorities for treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-2067.
18. Marks S, Taylor Z, Shrestha-Kuwahara R, Wilce M, Nguyen C. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000;162:2033-2038.
19. Reichler MR, Reves R, Bur S, Ford J, Thompson V, Mangura B, Onorato IM, Valway SE; Contact Investigation Study Group. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J 2002;95:414-420.
20. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med 2000;160:697-702.
21. LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis in a public health clinic. Am J Respir Crit Care Med 2003;168:443-447.
22. Cook PP, Maldonado RA, Yarnell CT, Holbert D. Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection. Clin Infect Dis 2006;43:271-275.
23. Gibson CJ, Lennon E. Nativity of the population and place of birth of the native population: 1850 to 1990 [Internet]. Washington (DC): U.S. Census Bureau; 1999 [revised 2001; accessed 2007 Jan 7]. Available from: http://www.census.gov/population/www/documentation/twps0029/tab01.html
24. Malone N, Baluja K, Costanzo J, Davis C. The foreign born population 2000. Census 2000 brief [Internet]. Washington (DC): U.S. Census Bureau; 2003 [accessed 2007 Jan 7]. Available from: http://www.census.gov/prod/2003pubs/ c2kbr-34.pdf
25. Gibson CJ, Lennon E. Region and country or area of birth of the foreign-born population: 1960 to 1990 [Internet]. Washington (DC): U.S. Census Bureau; 1999 [revised 2001; accessed 2007 Jan 7]. Available from: http://www.census.gov/population/www/documentation/twps0029/tab04.html
26. World Health Organization. 2003 Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2003. WHO/CDS/TB/2003.316.
27. U.S. Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR Recomm Rep 1996;45:1-18.
28. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002;57:804-809.
29. Advisory Council for the Elimination of Tuberculosis. Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995;44:1-16.
30. U.S. Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons. MMWR Recomm Rep 1998;47:1-29.
31. McKenna MT, McCray E, Jones JL, Onorato IM, Castro KG. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am J Public Health 1998;88:1059-1063.
32. Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, Cave MD. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis 2002;8:1280-1284.
33. Haddad MH, Wilson TW, Ijaz K, Marks FM, Moore M. Tuberculosis and homelessness in the United States, 1994-2003. JAMA 2005;293:2762-2766.
34. Stead WW. Undetected tuberculosis in prison: source of infection for the community at large. JAMA 1978;240:2544-2547.
35. Spencer SS, Morton AR. Tuberculosis surveillance in a state prison system. Am J Public Health 1989;79:307-310.
36. MacNeil JR, Lobato MN, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005;95:1800-1805.
37. Reider HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis 1995;76:114-121.
38. Neuenschwander B. Bayesian mixture analysis for tuberculin induration data for the International Union against Tuberculosis and Lung Disease, July 2007 [accessed 2007 Aug 10]. Available from: http://www.tbrieder.org/
39. Bloom BR. Enlightened self-interest and the control of tuberculosis. N Engl J Med 2005;353:1057-1058.